BioAge Labs, Inc. (BIOA)
20.51
+0.37
(+1.84%)
USD |
NASDAQ |
Feb 20, 16:00
20.13
-0.38
(-1.85%)
Pre-Market: 08:02
BioAge Labs Market Cap : 856.34M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 952.34B |
| Plus Therapeutics, Inc. | 37.79M |
| BioStem Technologies, Inc. | 101.50M |
| Iovance Biotherapeutics, Inc. | 1.139B |
| Protokinetix, Inc. | 3.069M |
Market Cap Related Metrics
| PS Ratio | 124.27 |
| PEG Ratio | -5.162 |
| Price to Book Value | 3.086 |
| Price | 20.51 |
| Earnings Yield | -10.31% |
| PEGY Ratio | -5.162 |